Pediatric Influenza Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: PA281608CDD9EN
Market Monitor Global

Abstracts

Most kids are enrolled in early education and child care programs. Seasonal influenza outbreaks are expected annually. Influenza can be severe, resulting in hospitalization or death of some children. Immunization against influenza is the best strategy to reduce infection and spread.

This report contains market size and forecasts of Pediatric Influenza Treatment in Global, including the following market information:

Global Pediatric Influenza Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Pediatric Influenza Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antiviral Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Pediatric Influenza Treatment include F. Hoffmann-La Roche Ltd, GlaxoSmithKline Plc., NATCO Pharma Limited., NESHER PHARMS, Johnson & Johnsons Inc., Cipla, Hetero Pharma, Teva Pharmaceutical pvt. Ltd. and Olainfarm JSC and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pediatric Influenza Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Pediatric Influenza Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Pediatric Influenza Treatment Market Segment Percentages, by Type, 2021 (%)

• Antiviral Drug
• Antipyretic
• Neuraminidase inhibitor
• Others

Global Pediatric Influenza Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Pediatric Influenza Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Global Pediatric Influenza Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Pediatric Influenza Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pediatric Influenza Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Pediatric Influenza Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• F. Hoffmann-La Roche Ltd
• GlaxoSmithKline Plc.
• NATCO Pharma Limited.
• NESHER PHARMS
• Johnson & Johnsons Inc.
• Cipla
• Hetero Pharma
• Teva Pharmaceutical pvt. Ltd.
• Olainfarm JSC
• Gilead Sciences, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Pediatric Influenza Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Pediatric Influenza Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL PEDIATRIC INFLUENZA TREATMENT OVERALL MARKET SIZE

2.1 Global Pediatric Influenza Treatment Market Size: 2021 VS 2028
2.2 Global Pediatric Influenza Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Pediatric Influenza Treatment Players in Global Market
3.2 Top Global Pediatric Influenza Treatment Companies Ranked by Revenue
3.3 Global Pediatric Influenza Treatment Revenue by Companies
3.4 Top 3 and Top 5 Pediatric Influenza Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Pediatric Influenza Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pediatric Influenza Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Pediatric Influenza Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Pediatric Influenza Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Pediatric Influenza Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antiviral Drug
  4.1.3 Antipyretic
  4.1.4 Neuraminidase inhibitor
  4.1.5 Others
4.2 By Type - Global Pediatric Influenza Treatment Revenue & Forecasts
  4.2.1 By Type - Global Pediatric Influenza Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Pediatric Influenza Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Pediatric Influenza Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Pediatric Influenza Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Ambulatory Surgical Centers
  5.1.5 Others
5.2 By Application - Global Pediatric Influenza Treatment Revenue & Forecasts
  5.2.1 By Application - Global Pediatric Influenza Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Pediatric Influenza Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Pediatric Influenza Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Pediatric Influenza Treatment Market Size, 2021 & 2028
6.2 By Region - Global Pediatric Influenza Treatment Revenue & Forecasts
  6.2.1 By Region - Global Pediatric Influenza Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Pediatric Influenza Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Pediatric Influenza Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Pediatric Influenza Treatment Revenue, 2017-2028
  6.3.2 US Pediatric Influenza Treatment Market Size, 2017-2028
  6.3.3 Canada Pediatric Influenza Treatment Market Size, 2017-2028
  6.3.4 Mexico Pediatric Influenza Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Pediatric Influenza Treatment Revenue, 2017-2028
  6.4.2 Germany Pediatric Influenza Treatment Market Size, 2017-2028
  6.4.3 France Pediatric Influenza Treatment Market Size, 2017-2028
  6.4.4 U.K. Pediatric Influenza Treatment Market Size, 2017-2028
  6.4.5 Italy Pediatric Influenza Treatment Market Size, 2017-2028
  6.4.6 Russia Pediatric Influenza Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Pediatric Influenza Treatment Market Size, 2017-2028
  6.4.8 Benelux Pediatric Influenza Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Pediatric Influenza Treatment Revenue, 2017-2028
  6.5.2 China Pediatric Influenza Treatment Market Size, 2017-2028
  6.5.3 Japan Pediatric Influenza Treatment Market Size, 2017-2028
  6.5.4 South Korea Pediatric Influenza Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Pediatric Influenza Treatment Market Size, 2017-2028
  6.5.6 India Pediatric Influenza Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Pediatric Influenza Treatment Revenue, 2017-2028
  6.6.2 Brazil Pediatric Influenza Treatment Market Size, 2017-2028
  6.6.3 Argentina Pediatric Influenza Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Pediatric Influenza Treatment Revenue, 2017-2028
  6.7.2 Turkey Pediatric Influenza Treatment Market Size, 2017-2028
  6.7.3 Israel Pediatric Influenza Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Pediatric Influenza Treatment Market Size, 2017-2028
  6.7.5 UAE Pediatric Influenza Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 F. Hoffmann-La Roche Ltd
  7.1.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.1.2 F. Hoffmann-La Roche Ltd Business Overview
  7.1.3 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Major Product Offerings
  7.1.4 F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.1.5 F. Hoffmann-La Roche Ltd Key News
7.2 GlaxoSmithKline Plc.
  7.2.1 GlaxoSmithKline Plc. Corporate Summary
  7.2.2 GlaxoSmithKline Plc. Business Overview
  7.2.3 GlaxoSmithKline Plc. Pediatric Influenza Treatment Major Product Offerings
  7.2.4 GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.2.5 GlaxoSmithKline Plc. Key News
7.3 NATCO Pharma Limited.
  7.3.1 NATCO Pharma Limited. Corporate Summary
  7.3.2 NATCO Pharma Limited. Business Overview
  7.3.3 NATCO Pharma Limited. Pediatric Influenza Treatment Major Product Offerings
  7.3.4 NATCO Pharma Limited. Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.3.5 NATCO Pharma Limited. Key News
7.4 NESHER PHARMS
  7.4.1 NESHER PHARMS Corporate Summary
  7.4.2 NESHER PHARMS Business Overview
  7.4.3 NESHER PHARMS Pediatric Influenza Treatment Major Product Offerings
  7.4.4 NESHER PHARMS Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.4.5 NESHER PHARMS Key News
7.5 Johnson & Johnsons Inc.
  7.5.1 Johnson & Johnsons Inc. Corporate Summary
  7.5.2 Johnson & Johnsons Inc. Business Overview
  7.5.3 Johnson & Johnsons Inc. Pediatric Influenza Treatment Major Product Offerings
  7.5.4 Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.5.5 Johnson & Johnsons Inc. Key News
7.6 Cipla
  7.6.1 Cipla Corporate Summary
  7.6.2 Cipla Business Overview
  7.6.3 Cipla Pediatric Influenza Treatment Major Product Offerings
  7.6.4 Cipla Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.6.5 Cipla Key News
7.7 Hetero Pharma
  7.7.1 Hetero Pharma Corporate Summary
  7.7.2 Hetero Pharma Business Overview
  7.7.3 Hetero Pharma Pediatric Influenza Treatment Major Product Offerings
  7.7.4 Hetero Pharma Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.7.5 Hetero Pharma Key News
7.8 Teva Pharmaceutical pvt. Ltd.
  7.8.1 Teva Pharmaceutical pvt. Ltd. Corporate Summary
  7.8.2 Teva Pharmaceutical pvt. Ltd. Business Overview
  7.8.3 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Major Product Offerings
  7.8.4 Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.8.5 Teva Pharmaceutical pvt. Ltd. Key News
7.9 Olainfarm JSC
  7.9.1 Olainfarm JSC Corporate Summary
  7.9.2 Olainfarm JSC Business Overview
  7.9.3 Olainfarm JSC Pediatric Influenza Treatment Major Product Offerings
  7.9.4 Olainfarm JSC Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.9.5 Olainfarm JSC Key News
7.10 Gilead Sciences, Inc.
  7.10.1 Gilead Sciences, Inc. Corporate Summary
  7.10.2 Gilead Sciences, Inc. Business Overview
  7.10.3 Gilead Sciences, Inc. Pediatric Influenza Treatment Major Product Offerings
  7.10.4 Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue in Global Market (2017-2022)
  7.10.5 Gilead Sciences, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Pediatric Influenza Treatment Market Opportunities & Trends in Global Market
Table 2. Pediatric Influenza Treatment Market Drivers in Global Market
Table 3. Pediatric Influenza Treatment Market Restraints in Global Market
Table 4. Key Players of Pediatric Influenza Treatment in Global Market
Table 5. Top Pediatric Influenza Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Pediatric Influenza Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Pediatric Influenza Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Pediatric Influenza Treatment Product Type
Table 9. List of Global Tier 1 Pediatric Influenza Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pediatric Influenza Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Pediatric Influenza Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Pediatric Influenza Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Pediatric Influenza Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Pediatric Influenza Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Pediatric Influenza Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Pediatric Influenza Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Pediatric Influenza Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Pediatric Influenza Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Pediatric Influenza Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Pediatric Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Pediatric Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Pediatric Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Pediatric Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Pediatric Influenza Treatment Revenue, (US$, Mn), 2023-2028
Table 30. F. Hoffmann-La Roche Ltd Corporate Summary
Table 31. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Product Offerings
Table 32. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 33. GlaxoSmithKline Plc. Corporate Summary
Table 34. GlaxoSmithKline Plc. Pediatric Influenza Treatment Product Offerings
Table 35. GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 36. NATCO Pharma Limited. Corporate Summary
Table 37. NATCO Pharma Limited. Pediatric Influenza Treatment Product Offerings
Table 38. NATCO Pharma Limited. Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 39. NESHER PHARMS Corporate Summary
Table 40. NESHER PHARMS Pediatric Influenza Treatment Product Offerings
Table 41. NESHER PHARMS Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Johnson & Johnsons Inc. Corporate Summary
Table 43. Johnson & Johnsons Inc. Pediatric Influenza Treatment Product Offerings
Table 44. Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Cipla Corporate Summary
Table 46. Cipla Pediatric Influenza Treatment Product Offerings
Table 47. Cipla Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Hetero Pharma Corporate Summary
Table 49. Hetero Pharma Pediatric Influenza Treatment Product Offerings
Table 50. Hetero Pharma Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceutical pvt. Ltd. Corporate Summary
Table 52. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Product Offerings
Table 53. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Olainfarm JSC Corporate Summary
Table 55. Olainfarm JSC Pediatric Influenza Treatment Product Offerings
Table 56. Olainfarm JSC Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Gilead Sciences, Inc. Corporate Summary
Table 58. Gilead Sciences, Inc. Pediatric Influenza Treatment Product Offerings
Table 59. Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Pediatric Influenza Treatment Segment by Type in 2021
Figure 2. Pediatric Influenza Treatment Segment by Application in 2021
Figure 3. Global Pediatric Influenza Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Pediatric Influenza Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Pediatric Influenza Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pediatric Influenza Treatment Revenue in 2021
Figure 8. By Type - Global Pediatric Influenza Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Pediatric Influenza Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Pediatric Influenza Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Pediatric Influenza Treatment Revenue Market Share, 2017-2028
Figure 12. US Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Pediatric Influenza Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Pediatric Influenza Treatment Revenue Market Share, 2017-2028
Figure 24. China Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Pediatric Influenza Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Pediatric Influenza Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Pediatric Influenza Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. F. Hoffmann-La Roche Ltd Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GlaxoSmithKline Plc. Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. NATCO Pharma Limited. Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. NESHER PHARMS Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Johnson & Johnsons Inc. Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Cipla Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hetero Pharma Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceutical pvt. Ltd. Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Olainfarm JSC Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Gilead Sciences, Inc. Pediatric Influenza Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)